Recent Articles from Investor Brand Network

A group of cannabis businesses has asked the U.S. Supreme Court to review the constitutionality of the federal government’s ongoing prohibition on marijuana.

Micropolis (NYSE American: MCRP), a pioneer in unmanned ground vehicles (“UGVs”) and AI-driven robotics solutions, recently announced a major step in its international expansion strategy through an exclusive distribution agreement with AERXIO FZ-LLC. An article discussing this reads, “AERXIO, a UAE-based technology provider, will serve as the sole distributor of Micropolis’s advanced unmanned ground security vehicles and related technologies across Egypt and North Africa… The agreement provides AERXIO exclusive rights to market Micropolis’s ‘The Patrol’ platform. This autonomous unit is designed for both open-road and desert environments, with operational speeds of up to 50 km/h, a 15-hour runtime, rapid charging, and the integration of Microspot AI software. It is optimized for security, surveillance, and border protection… By combining proprietary AI with customizable robotics, Micropolis is positioning itself as a promising investment opportunity at the intersection of automation, security, and smart infrastructure, a combination that may attract both government contracts and private partnerships across emerging and developed markets alike.”

Nightfood Holdings (OTCQB: NGTF) is eying opportunity in the evolving landscape of hospitality. A recent article discussing this reads, “Robotics and automation are no longer futuristic aspirations; they are rapidly reshaping hospitality operations today. Nightfood is pioneering this transformation with advanced AI-enabled robotic solutions designed to elevate service quality, optimize operational efficiency and enhance guest experience across the industry… Nightfood Holdings is positioning itself as an innovative leader. Through its subsidiary, the company is focused on hospitality automation. Operating as RoboOp365, FHVH develops AI-robotic systems aimed at streamlining operations within food service and guest-facing environments. This includes showcasing its AI-driven kitchen and culinary automation systems at the California Restaurant Show, reinforcing its commitment to automation in foodservice contexts… The global service robotics market is signaling widespread adoption of AI and robotic solutions across hotel and hospitality operations. Against this backdrop, RoboOp365’s technology, integrating robotics into culinary workflows and beyond, is well positioned to capture attention in this surging market.”

OptimumBank Holdings (NYSE American: OPHC) showcased its strong financial performance and strategic vision at two major October conferences. The Fort Lauderdale-based company reported robust second-quarter earnings of $3.6 million and surpassed $1 billion in total assets, reflecting double-digit deposit growth and rising net interest income. Chairman Moishe Gubin represented the Bank at the LD Micro Main Event in San Diego and, later, OptimumBank attended the Jewish National Fund’s Global Conference in Hollywood, Florida. These appearances followed a recent sponsorship of the 2025 Brokers Expo in New York and underscore OPHC’s focus on relationship-driven banking, tech modernization, and investor engagement. A recent feature on Gubin’s entrepreneurial journey highlights his leadership in fueling OptimumBank’s growth.

Micropolis (NYSE American: MCRP), a pioneer in unmanned ground vehicles (“UGVs”) and AI-driven security solutions, announced that it has entered into an agreement with Helsingborgs Hamn AB, operator of the Port of Helsingborg in Sweden, and MCS Robotics AB, a Swedish robotics firm, to jointly develop and test the Box Cleaner, an autonomous robotic cleaning system designed for port and industrial environments ( https://ibn.fm/HJXkz ).

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) announced final geochemical assay results from its 2025 winter drill program at the Hatchet Lake Uranium Property in Saskatchewan’s eastern Athabasca Basin. The results confirm and enhance previously reported radiometric data, showing a significant grade increase for drill hole TF-25-16—now returning 0.87% U₃O₈ over 0.45 meters from 149.75 meters, compared to an earlier estimate of 0.22% over 0.9 meters. Assays indicate 6.2 meters of total mineralization grading 0.10% U₃O₈ within a Graphitic Shear Zone and associated alteration features, suggesting proximity to a larger mineralizing system.

NetworkNewsWire Editorial Coverage : The rapid ascent of artificial intelligence (“AI”) isn’t being slowed by a lack of computing power, it’s being constrained by electricity. As AI expands globally, data centers are consuming energy at an unprecedented rate, outpacing what utilities can deliver, overloading aging grids and driving up costs for consumers. The result is a growing realization: the digital economy urgently needs a new, scalable source of clean energy. One emerging contender is natural hydrogen. The International Energy Agency (“IEA”) projects that global data-center electricity demand will more than double by 2030 to nearly 945 terawatt-hours (“TWh”), with AI-optimized facilities expected to quadruple their consumption over the same period. In the United States, data-center power use could also double by 2035, reaching roughly 9% of national electricity demand. Simply put, computing growth is outstripping the pace of grid expansion. That’s why leading tech companies and investors are turning their focus to securing energy itself. One of the most promising new frontiers in that pursuit is natural, or geologic, hydrogen. MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX) ( profile ) stands at the forefront of this movement as the first publicly traded company in North America dedicated to commercial natural hydrogen. The company controls about 1.3 million permitted acres in Saskatchewan, including the 124-mile-long Genesis Trend, positioned alongside an industrial corridor and proposed Hydrogen Hub, with multiple high-priority targets. With its mission to meet the soaring energy demands of AI, MAX Power joins leading AI innovators such as Alphabet Inc. (NASDAQ: GOOG), Meta Platforms Inc. (NASDAQ: META), Tesla Inc. (NASDAQ: TSLA) and Advanced Micro Devices Inc. (NASDAQ: AMD), each advancing the intersection of…

NetworkNewsWire Editorial Coverage : The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, limit toxicity and elevate patient outcomes. Conventional oral and intravenous treatments continue to face significant challenges, chief among them low bioavailability and inadequate tumor targeting. These factors often limit the success of these treatments in clinical settings. Breakthroughs in nanomedicine are now addressing these obstacles, with growing support from the U.S. Food and Drug Administration (“FDA”), along with other regulators for nanocarrier-based delivery technologies used in advanced therapeutics. This accelerating adoption highlights a broader shift across the industry: a race to optimize how medicines are transported, absorbed, and activated within the human body. Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( profile ) is at the forefront of this movement with its proprietary Deciparticle(TM) platform, designed to enhance both the bioavailability and therapeutic index of existing oncology drugs. By improving the performance of underutilized compounds, the technology could help redefine standards for cancer treatment. The company’s recent advancement of Sapu-003 into human trials reflects growing traction for this approach, demonstrating how next-generation delivery science can unlock new therapeutic value and reshape the future of oncology innovation. Oncotelic Therapeutics is committed to making a difference in the global oncology space, positioning itself as an innovator along with other companies working to make a difference in cancer treatment, including Iovance Biotherapeutics Inc . (NASDAQ: IOVA), Merck & Co. Inc. (NYSE: MRK), Eli Lilly and Company (NYSE: LLY) and…

POET Technologies (NASDAQ: POET), the designer and developer of the POET Optical Interposer(TM), Photonic Integrated Circuits (PICs), and light sources for data center, telecommunications, and AI markets, announced it has entered securities purchase agreements with institutional investors for the sale of 20,689,655 common shares in an oversubscribed registered direct offering expected to raise approximately $150 million in gross proceeds. The Company plans to use the funds to support corporate development, targeted acquisitions, R&D expansion, acceleration of its light source business, and general working capital.

NanoViricides, Inc. (NYSE American: NNVC) announced that CEO Dr. Anil Diwan discussed major advances in the company’s antiviral research during a video interview with Proactive, available at https://youtu.be/m_3Yk4_832E . Dr. Diwan reported that NanoViricides’ lead candidate, NV-387, showed strong anti-Measles activity in both cell culture and humanized animal models, extending survival by 130% and protecting lung tissue in severe infection stages. With no approved Measles treatments currently available, the findings underscore NV-387’s broad-spectrum potential. The drug has completed Phase I human trials with no reportable adverse events and is advancing to Phase II for MPox. NanoViricides is positioned to support FDA emergency use applications and investigator-initiated INDs for urgent Measles cases.

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and products, announced strong initial dealer demand for its new MVR Golf Cart and MVR Cargo Max Electric Utility Cart, with more than $1.5 million in early dealer commitments following the launch of its Vietnam production partnership and new Lithium-Ion power options. “Our dealer network’s response has been tremendous,” said David Shan, CEO of Massimo Group. “This level of enthusiasm and commitment so quickly after launch validates our product strategy and the strength of our global manufacturing partnerships.” The MVR Series features 48V 105Ah Lithium-Ion systems offering greater range, faster charging, and extended battery life compared to lead-acid platforms. Massimo will showcase the lineup at the upcoming PGA Show in Orlando, Florida, as the company continues expanding its electric mobility portfolio.

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, announced it has received an additional 180-calendar-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). The Company now has until April 27, 2026, to achieve a closing bid price of at least $1.00 per share for ten consecutive business days. The extension does not affect the continued listing of NextPlat’s common stock on the Nasdaq Capital Market. Nasdaq granted the extension after confirming the Company meets all other listing criteria and has indicated its intent to regain compliance, if necessary, through a reverse stock split.

Datavault AI (NASDAQ: DVLT), a leader in patented data tokenization and monetization technologies, announced it has entered a definitive agreement to acquire API Media in December 2025. The acquisition will expand Datavault’s AI-powered data activation and monetization capabilities while preserving API’s brand and strengthening its operations with Datavault’s patented technologies. API Media, based in New Jersey, provides advanced audio, visual, and IT services for premier sports venues and enterprise clients. “This acquisition marks a decisive next step in our strategy to scale Datavault’s proprietary data-monetization ecosystem,” said Nathaniel Bradley, CEO of Datavault AI. “API Media’s brand and expertise will enrich our culture and enhance the value we deliver to enterprise clients through verified, tokenized data assets.” API Media executives Frank Tomaino and David Reese said the deal will expand client access to AI, analytics, and secure data monetization tools while accelerating Datavault’s growth and recurring revenue across data, advertising, and AI-as-a-Service markets.

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) today announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Pivoting from Exploration to Production: Mining’s Moment,” which highlights how rising precious metal prices and global market uncertainty are reshaping mining investment opportunities. The feature underscores LaFleur’s transition from explorer to producer, noting the company’s fully permitted, refurbished gold-processing mill and its advantageous position relative to peers still in exploration.

Chinese electric vehicles are quickly changing the face of the global car market, and their strongest weapon is technology. Over the past few years, Chinese brands have stepped up their game, offering modern, affordable, and highly advanced electric cars that are attracting huge attention from drivers in the UK and beyond.

AMD shares surged by nearly 8% on Friday after IBM announced that standard AMD chips can run a critical quantum computing error correction algorithm. Investors’ response to the breakthrough in qubit technology advancement caused IBM stock to climb approximately 8% as well, heading toward its best single-day performance since January.

Analysts have made upward revisions of their forecasts for the price of copper in 2026 after a number of incidents at major mines deepened concerns about market deficits. Benchmark copper contracts on the LME reached their highest price in 17 months this October after news filtered through regarding production disruptions in Congo, Chile and Indonesia.

McEwen (NYSE: MUX) (TSX: MUX) announced it has amended and refiled its “NI 43-101 Technical Report on the Mineral Resources Estimate of the Fox Complex, Ontario, Canada,” originally filed April 4, 2025, following a review by the Ontario Securities Commission as part of its continuous disclosure program. The updated report now includes additional information required under Items 16 to 22 of Form 43-101F1 for an advanced property and replaces John Ryan Cox as a co-author to ensure compliance with Qualified Person requirements. No other changes were made, and the Mineral Resources statements for the Fox Complex remain unchanged.

A new study suggests that states allowing medical cannabis sales through licensed dispensaries may see fewer prescriptions for strong opioids among cancer patients recovering from surgery. However, the same policy appears to coincide with a higher rate of hospital visits for reasons unrelated to cancer treatment.

Trilogy Metals (NYSE American: TMQ) (TSX: TMQ), leveraging its copper-rich assets in Alaska, is strategically positioned amidst a wave of favorable policy changes. “First, the U.S. House of Representatives passed a resolution to overturn restrictive land designations in central Yukon, opening up millions of acres previously locked from development. Second, federal executive action has advanced the proposed Ambler Access Road in Northwest Alaska, a long-sought industrial corridor that Trilogy has noted is essential to accessing its mining assets in the Ambler Mining District. Together, these moves reduce key regulatory obstacles for Trilogy Metals and sharpen the prospects for its copper-dominant polymetallic projects,” reads a recent article. “As demand for metals essential to clean energy and electrification increase, companies such as Trilogy are in the spotlight. With government action now aligning more toward unlocking mineral lands and facilitating infrastructure, Trilogy has an opportunity to progress from exploration toward full development—and possibly transform its projects in the Ambler Mining District into leading contributors to the mineral security of both Alaska and the United States.”

SuperCom (NASDAQ: SPCB) has expanded its U.S. presence to 12 states through a new electronic monitoring project with a sheriff’s department in Wisconsin. According to a recent article, the initiative, part of a domestic violence prevention program, will use SuperCom’s PureSecurity(TM) platform—integrating GPS, RFID, cloud-based monitoring technologies—to track offenders and enhance public safety. Operating under a recurring revenue model, the project reflects growing national demand for modern alternatives to incarceration. Since August 2024, SuperCom has signed over 30 U.S. contracts and 11 reseller partnerships, leveraging its modular EM solutions including PureOne(TM), PureShield(TM), PureProtect(TM), and PureMonitor(TM). The company’s technology aligns with global evidence demonstrating that monitoring reduces recidivism and with its strategy of delivering scalable, cost-effective public safety tools while expanding its footprint.

Universal Digital (CSE: LFG) (FSE: 8R20) (OTCQB: LFGMF) has entered a subscription agreement with Helena Global Investment Opportunities 1 Ltd. for a private placement of up to $50 million in senior secured convertible debentures to be issued in up to 14 tranches, with the first $3.34 million tranche expected to close on or about Oct. 31, 2025. The one-year debentures will bear 17.5% annual interest, be convertible at 100% of the prior day’s CSE closing price (subject to a $0.05 minimum), and be secured by all current and acquired Bitcoin holdings. Each tranche will also include warrants equal to 25% of the tranche amount, exercisable for three years at 130% of the prior day’s closing price. “This financing framework provides Universal Digital with a flexible, scalable capital structure to support our Bitcoin Treasury Strategy and future digital-asset initiatives,” said CEO Chris Yeung.

Beeline Holdings (NASDAQ: BLNE) CEO and Co-Founder Nick Liuzza discussed the company’s growth trajectory and industry outlook in an exclusive interview with Benzinga, following the launch of BeelineEquity, the nation’s first blockchain-powered home-equity platform. The platform enables homeowners—particularly baby boomers seeking liquidity—to sell fractional equity in their properties without taking on debt or monthly payments, with each transaction tokenized on blockchain. Liuzza told Benzinga that Beeline closed five equity transactions last week, expects about 25 more within 45 days, and is already taking 2026 applications amid strong demand. He said the company plans to scale nationwide as anticipated interest rate cuts improve housing affordability and create powerful tailwinds for the digital mortgage sector.

Beeline Holdings (NASDAQ: BLNE) CEO and Co-Founder Nick Liuzza discussed the company’s growth trajectory and industry outlook in an exclusive interview with Benzinga, following the launch of BeelineEquity, the nation’s first blockchain-powered home-equity platform. The platform enables homeowners—particularly baby boomers seeking liquidity—to sell fractional equity in their properties without taking on debt or monthly payments, with each transaction tokenized on blockchain. Liuzza told Benzinga that Beeline closed five equity transactions last week, expects about 25 more within 45 days, and is already taking 2026 applications amid strong demand. He said the company plans to scale nationwide as anticipated interest rate cuts improve housing affordability and create powerful tailwinds for the digital mortgage sector.

MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) announced the development of its MAX Power Large Earth Model Integration (“MAXX LEMI”) for Natural Hydrogen, an advanced exploration system soon to be enhanced by artificial intelligence as part of the Company’s push toward the world’s first commercial Natural Hydrogen discovery. Canada’s first deep well targeting Natural Hydrogen is expected to begin drilling around Nov. 7 on MAX Power’s 200-km-long Genesis Trend in southern Saskatchewan, with additional wells planned across its 1.3-million-acre land package. Overseen by Chief Geoscientist Steve Halabura, P.Geo., and supported by the Petroleum Technology Research Centre, MAXX LEMI integrates extensive regional datasets and is evolving into a scalable, AI-assisted blueprint for global Natural Hydrogen exploration. The system will be highlighted at the Natural Hydrogen Summit in Paris on Nov. 13-14, 2025.

ESGold (CSE: ESAU) (OTCQB: ESAUF) reported that metallurgical work at its fully permitted Montauban Gold-Silver Project in Quebec has validated the Company’s processing strategy for all site feedstock, including railway tailings, confirming the Merrill Crowe closed circuit as the optimal processing path. Gravity separation tests showed concentrate grades were insufficient for direct gold and silver pouring, leading to confirmation that all material will be processed through the Merrill Crowe system during the final construction phase. The results, supervised by Edmond St-Jean, P.Eng., and analyzed by ALS Global in Val-d’Or, de-risk equipment procurement and support ongoing mill construction, which is ahead of schedule. ESGold also noted continued infrastructure expansion, including the gold room and laboratory, and completion of advanced 3D geological modeling to guide an expanded exploration program.

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its RADR(R) AI platform to transform oncology drug discovery and development, presented clinical data from its ongoing Phase 1 trial of LP-284 at the 25th Annual Lymphoma, Leukemia & Myeloma Congress in New York City, showing a confirmed complete metabolic response in a 41-year-old patient with aggressive Grade 3 non-germinal center B-cell diffuse large B-cell lymphoma after failure of four prior regimens, including CAR-T and bispecific antibody therapies. The response, achieved after two 28-day cycles of LP-284, supports the drug’s synthetic lethal mechanism and potential to fill a critical post-immunotherapy treatment gap. Lantern CEO Panna Sharma said the results validate the company’s AI-driven approach and highlight LP-284’s dual potential as a monotherapy and in combination with FDA-approved agents such as rituximab. Lantern noted LP-284’s favorable early safety profile, multiple FDA Orphan Drug Designations, strong IP protection through 2039, and partnership opportunities for expanding hematology portfolios.

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, today announced it has received final meeting minutes from its Sept. 18, 2025, virtual meeting with the U.S. Food and Drug Administration (FDA) regarding its lead product, AVERSA(TM) FENTANYL, an abuse-deterrent fentanyl transdermal system. The meeting with the Division of Anesthesiology, Addiction Medicine, and Pain Medicine confirmed the regulatory pathway as a 505(b)(2) New Drug Application and provided guidance on the reference listed drug and bridging strategy. The FDA also offered feedback on manufacturing validation, product specifications, and stability testing, along with expectations for in vitro manipulation and extraction studies to characterize AVERSA’s abuse-deterrent properties for potential NDA submission.

SKYX Platforms (NASDAQ: SKYX), doing business as SKYX Technologies, announced an agreement with Chicago-based Global Ventures Group to deploy its advanced smart home and building technologies across residential, commercial, and hotel projects in the Middle East, including developments in Saudi Arabia and Egypt. The collaboration supports SKYX’s global expansion strategy and mission to make homes and buildings smarter, safer, and more connected. SKYX expects to supply hundreds of thousands of units of its plug & play smart products, including ceiling lighting, fans, recessed and wall lights, EXIT and emergency lights, and LED mirrors. Global Ventures Group, led by Founder and CEO Randall Langer, will integrate SKYX’s technologies to enhance safety, convenience, and design standards throughout the region.

Cybin (NYSE American: CYBN) (Cboe CA: CYBN) announced a registered direct offering of 22,277,750 common shares and, in lieu of shares for certain investors, pre-funded common share purchase warrants at US$6.51 per share or pre-funded warrant for aggregate gross proceeds of US$175,009,911.45; each share or pre-funded warrant is accompanied by 0.35 of one common share purchase warrant exercisable at US$8.14 per share until the earlier of June 30, 2027, 30 days after topline data is released for the APPROACH trial of CYB003 in major depressive disorder, or 30 days after an acceleration notice if the NYSE American closing price equals or exceeds US$19.53 for five consecutive trading days; participants include new and existing investors such as Venrock Healthcare Capital Partners, OrbiMed, Point72, Deep Track Capital, Acorn Bioventures, Spruce Street Capital, Squadron Capital Management, Adage Capital Partners LP, Boxer Capital Management, ADAR1 Capital Management, Stonepine Capital Management, Pivotal Bioventure Partners and Ally Bridge Group.

Datavault AI (NASDAQ: DVLT), a leader in patented data tokenization and monetization technologies, today announced a definitive licensing agreement with Nature’s Miracle Holding Inc. (OTCQB: NMHI), a sustainable agriculture and environmental technology company. Under the deal, Nature’s Miracle will license Datavault AI’s patented Carbon Credit Tokenization System, gaining global rights to develop, distribute, and commercialize blockchain-powered carbon credit solutions. Datavault AI will receive a non-refundable $2 million license fee and a 35% royalty on all gross revenue from the technology. “This agreement represents a significant milestone in Datavault AI’s ongoing strategy to commercialize our patent portfolio across high-growth industries like sustainability and carbon markets,” said Nathaniel Bradley, CEO. The partnership enables scalable, transparent, and fraud-resistant carbon credit verification and trading while enhancing sustainability reporting through blockchain integration.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, today announced a partnership with HeartNexus Inc., a network of board-certified cardiologists specializing in cardiac test interpretation, peer consultations, and telemedicine visits. The collaboration enables HeartBeam to offer 24/7 cardiology reader services for patients experiencing cardiac symptoms outside traditional care settings. Using HeartBeam’s patented 3D technology, patients can capture a 30-second, cable-free ECG recording anytime symptoms occur, transmitting the data to HeartNexus cardiologists for immediate interpretation. “Working with HeartNexus accelerates our mission to make medical-grade cardiac monitoring accessible beyond the walls of a medical facility,” said Robert Eno, CEO of HeartBeam. The partnership expands HeartBeam’s ecosystem with real-time cardiology feedback and future integration of AI wellness and wearable features.

Datavault AI (NASDAQ: DVLT), a leader in data tokenization and management, today announced the launch of two new data unions: the Insurance Data Union, in partnership with the Independent Insurance Agents & Brokers of America (Big “I”) and independent agents nationwide; and the Accounting Data Union, collaborating with leading accounting firms across all 50 states. These initiatives will tokenize anonymized insurance and accounting data using Datavault AI’s patented technologies and Information Data Exchange to enable secure, scalable monetization. “Few markets have the data assets of insurance and accounting,” said Tim Varone, a longtime advisor to Datavault AI. “Data unions, enabled by smart contracts and high-performance computing, have changed what’s possible.” The unions will compensate participants for qualified assets scored through Datavault AI’s patented DataScore, DataValue, and Data Vault Bank systems.

MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) today announced its inclusion in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio @ IBN (InvestorBrandNetwork), a communications platform specializing in financial news and content distribution. The article, titled “AI’s Growth Has a Power Problem — Natural Hydrogen Could Be the Perfect Solution,” explores the surging electricity demand driven by artificial intelligence and data centers, and how natural hydrogen could address this global energy challenge. MAX Power, a first mover in North America’s emerging natural hydrogen sector, controls approximately 1.3 million permitted acres in Saskatchewan, including the 124-mile-long Genesis Trend near a proposed Hydrogen Hub.

Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer. It resists existing treatments and recurs in all patients, with a relatively short survival time averaging 14-18 months. Understanding the rate of remission for this disease can therefore enable patients and their caregivers to have a clear picture of what to expect, and therefore be guided in making any decisions they need to make. We discuss some of the factors influencing remission in GBM.

Latest figures released by the U.S. Bureau of Statistics show that inflation increased by 3% over the last year, with the consumer price index also rising by 0.3% in September. This announcement saw the price of gold surge to $4,088.52 an ounce as many investors turned to the precious metal to hedge against rising inflation.

A 16-year-old student in Baltimore County was handcuffed by police after an AI security system incorrectly identified a bag of chips as a firearm. Taki Allen, a high school athlete, told WMAR-2 News that police arrived in force. “There were like eight police cars,” he said. “They all came out with guns pointed at me, shouting to get on the ground.”

Hyundai Motor Company has filed a patent for an unconventional battery architecture that positions energy storage behind the driver, replicating the mid-engine configuration found in performance vehicles. The South Korean automaker’s T-shaped battery arrangement aims to deliver balanced mass allocation and handling dynamics that are similar to high-performance sports cars without impacting electric vehicle efficiency.

NetworkNewsWire Editorial Coverage : Over the past year, gold, silver and other precious metals have staged a consistent up-move that is reshaping the investment case for the mining sector. Driven by inflation pressures, global uncertainty, central-bank buying and tight supply, the precious-metals complex today offers more than a safe-haven hedge: it presents a credible growth opportunity. While equities remain volatile and many sectors face structural headwinds, mining companies tied to precious metals are emerging as both compelling and relatively stable investment options. Amid this backdrop, the timing of a mining company’s transition from exploration to production becomes especially significant. It is precisely when a junior miner pivots into producer status — when it has defined assets, a processing route and imminent cash flow — that the upside potential is often greatest as earlier exploration uncertainty has been resolved and asset value starts to convert from potential into concrete economics. One company offering a striking example of this pivot is LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) ( Profile ). LaFleur holds a fully permitted and recently refurbished gold-processing mill, is years ahead of many of its peer explorers who have yet to secure production assets, and presently trades at a discount to its asset value. By combining a near-term producer trajectory with undervalued assets, Lafleur is strengthening its position with others operating in the mining space, including Nicola Mining (OTCQB: HUSIF), West Red Lake Gold Mines Ltd . (OTCQB: WRLGF), ESGold Corp. (OTCQB: ESAUF) and…

Oncotelic Therapeutics (OTCQB: OTLC) today announced its inclusion in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio @ IBN (InvestorBrandNetwork), a communications platform specializing in financial news and content distribution. The article, titled “Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology,” highlights how nanocarrier-based delivery systems are transforming cancer treatment. Oncotelic’s Deciparticle(TM) platform exemplifies this progress by improving bioavailability and therapeutic index across multiple oncology drugs. The advancement of Sapu-003, Intravenous Deciparticle(TM) Everolimus (Afinitor(R)), into human trials underscores the company’s innovation in drug delivery and its mission to enhance efficacy and patient outcomes.

VenHub Global, a developer of fully autonomous Smart Store technology, today announced it has joined the National Retail Federation (NRF) as an Industry Partner Member. As part of the world’s largest retail trade association, VenHub gains access to NRF research, councils, and industry forums to share its expertise in automation and data-driven merchandising. “Joining NRF marks an exciting step for VenHub,” said Shahan Ohanessian, CEO. “As part of the retail community’s largest network, we can exchange ideas, showcase our autonomous store platform, and learn from industry leaders.” VenHub’s Smart Stores integrate robotics, automation, and mobile-first technology for a fully contactless, 24/7 shopping experience. The company plans to participate in NRF events, including Retail’s Big Show, to demonstrate its latest innovations in autonomous retail.

Safe & Green Holdings (NASDAQ: SGBX) has announced that its wholly owned subsidiary, Olenox Energy Corp., a vertically integrated energy company, is advancing an aggressive drilling program set to begin in the fourth quarter of 2025. The initiative, part of the company’s strategy to strengthen its energy production base, will expand across 2026 as Olenox ramps up both legacy and new well development within its oil and gas portfolio.

Newton Golf Company (NASDAQ: NWTG), a leading innovator in performance-driven golf equipment, today announced the launch of its dedicated Japanese e-commerce site, www.newtongolf.jp . The new platform enables golfers in Japan to purchase Newton’s performance-engineered products directly, marking a key milestone in the company’s global expansion. With golf participation rising across Japan, the site offers localized access to Newton’s advanced technologies, including its proprietary DOT System(TM) within Newton Motion Shafts and soon-to-launch Gravity Putters, designed to enhance precision, balance, and performance for golfers at every level.

Current vaccines for Ebola and similar filoviruses face a major deployment barrier: Most require storage between 2°C and 8°C throughout transport, making them vulnerable to spoilage when exposed to the high ambient heat common in many outbreak regions ( https://ibn.fm/MZWfk ). Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in biodefense and rare disease vaccines, has published a peer-reviewed summary of new scientific data demonstrating long-term high-temperature stability of its protein subunit vaccine platform designed for Ebola and Marburg-related viruses ( https://ibn.fm/F2JpN ).

A coalition of retired senior military officers has called for renewable energy investments to be classified as defense expenditures, arguing that climate-related threats constitute legitimate national security concerns. Former European commanders contend that allocating resources toward low-carbon power generation would strengthen resilience against potential adversaries while reducing dependence on hostile nations controlling fossil fuel supplies.

JPMorgan is planning to let institutional clients use their Ether and Bitcoin holdings as loan collateral before the end of this year, signaling another major step in Wall Street’s growing acceptance of digital assets.

JPMorgan Chase & Co. is making bold moves to grow its investment banking business by hiring top talent from its biggest rivals, Deutsche Bank and Goldman Sachs. The bank recently brought in three senior bankers as part of its plan to expand its business services division, which focuses on companies providing essential services such as cleaning, maintenance, and infrastructure support.

Over 160 Floridians with state-issued medical cannabis cards have lost or could soon lose access to their prescriptions following a new regulation from the state health department. The rule, enacted this summer, targets patients charged with or convicted of drug-related offenses.

Octane, Southern California’s premier innovation accelerator, is set to host its 2025 Medical Innovation Forum on Oct. 28–29 at the Irvine Marriott. The two-day forum will feature more than 50 experts and leaders who will share insights on cutting-edge advancements in the latest medical trends, including foresights in longevity, wellness, and technology. Dr. Shaista Malik and Dr. Claudia Kawas will take the stage to deliver keynote presentations on longevity, including groundbreaking findings from a 90+ study and new insights in heart and brain health, emotional well-being, and resilience across a lifetime. Attendees will also experience an engaging fireside chat with Octane co-founder Jim Mazzo and Willow Laboratories founder Joe Kiani, the new Integrative Wellness Pavilion, as well as capital pitch presentations from 14 entrepreneurs.

The Blockchain Futurist Conference Florida 2025, now in its eighth edition and first-ever U.S. event, is gearing up to deliver an unforgettable experience shaping the future of Web3, crypto, and AI. Taking place November 5–6, 2025, at DAER inside the iconic Hard Rock Guitar Hotel, this festival-style conference will be the ultimate destination for high-impact networking and deal flow.

Datavault AI (NASDAQ: DVLT), a leader in AI data experience, valuation, and monetization, has entered a SaaS agreement with Wellgistics Health Inc. (NASDAQ: WGRX) to co-develop PharmacyChain(TM), a blockchain-enabled smart contract system designed to optimize prescription distribution from manufacturers to patients. The collaboration leverages Datavault AI’s patented Information Data Exchange(R) platform to create secure, token-driven data transfers that enhance transparency and efficiency in pharmaceutical logistics. CEO Nathaniel Bradley said the partnership will build digital twins of logistics, delivery systems, and patients, supporting personalized health recommendations and new revenue streams in the $639 billion prescription drug market.

SEGG Media (NASDAQ: SEGG, LTRYW), a global sports, entertainment, and gaming group, announced the official launch of its new Sports.com App, now available on the Apple App Store and other marketplaces. The platform integrates live and on-demand sports, highlights, and interactive features into a single hub aimed at driving fan engagement and monetization across emerging markets. The app debuts with live coverage of the Oct. 28 Super League Kerala match between Malappuram FC and Thiruvananthapuram Kombans FC, following record-breaking viewership that surpassed 14.5 million interactions last week. CEO Tim Scoffham said the launch marks a key step in unifying SEGG Media’s sports ecosystem worldwide.

Glidelogic (USOTC: GDLG) reported that its Policy Intelligence Suite achieved an 83.8% weighted forecast hit rate in predicting key outcomes of China’s Fourth Plenary Session of the 20th Central Committee, including 10 full, 4 partial, and 2 early or weak matches tied to the nation’s 15th Five-Year Plan (2026–2030). The validation underscores the predictive strength of Glidelogic’s AI-driven platform, which accurately anticipated priorities such as “AI+” integration, innovation-led growth, and gradual delayed retirement. Founder Fred (Yitian) Xue said the results demonstrate how AI-based policy foresight transforms uncertainty into actionable intelligence for decision-makers.

MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) announced the identification of “Bracken” as its first high-priority Natural Hydrogen drill target beyond the 200-km Genesis Trend in Saskatchewan. Located 15 km north of the Montana border within the company’s 120,000-acre Grasslands Project, Bracken lies in a distinct geological zone characterized by a unique rock assemblage and proximity to known hydrogen and helium occurrences. MAX Power plans to acquire new 2D seismic data this quarter to define optimal drill locations, complementing its upcoming Lawson well, which will be Canada’s first deep test dedicated to Natural Hydrogen.

Gold has entered a defining moment. With prices hovering near record highs near $4,200 an ounce and some forecasts now calling for $5,000 gold within a year, the macro backdrop for precious metals has rarely looked stronger. Central banks continue to diversify out of fiat currencies, inflation remains stubbornly above target, and geopolitical risks are rewriting the global investment playbook.

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is spotlighted in a NetworkNewsAudio release titled “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” highlighting its IzoView Breast CT Imaging System. Positioned between tomosynthesis and MRI, IzoView integrates high-resolution volumetric imaging with proprietary AI reconstruction for enhanced diagnostic precision. Built on over a decade of breast CT data and designed for potential CADx integration, the system underscores Izotropic’s leadership in AI-driven breast cancer detection.

A new study has revealed that Kia’s electric and plug-in hybrid vehicles are leading the pack when it comes to battery longevity, outperforming Tesla in how well their batteries retain capacity over time. The research, which tested hundreds of used electric vehicles, shows that battery life in secondhand EVs is far better than many people expected.

A recent study has found that the cognitive difficulties which cancer patients experience during and after treatment could stem from chemotherapy-induced damage to the brain’s waste drainage network. Newly discovered evidence sheds light on a widespread yet poorly understood phenomenon that affects up to 75% of individuals undergoing cancer therapy, chemo brain . The symptoms associated with this condition, including memory lapses and problems with concentration and finding words, typically persist long after treatment is complete.

NetworkNewsWire Editorial Coverage : The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity and improve patient outcomes. Traditional oral or IV drugs often face poor bioavailability and limited tumor targeting — a major bottleneck in cancer treatment success. Recent breakthroughs in nanomedicine are making headlines, as the FDA and global regulatory bodies increasingly endorse nanocarrier-based delivery for complex drugs. This surge underscores a larger industry trend: the race to improve how drugs reach and act within the body. Oncotelic Therapeutics Inc.’s (OTCQB: OTLC) ( profile ) Deciparticle(TM) platform exemplifies this shift. It offers a novel approach to increase the bioavailability and therapeutic index of existing cancer drugs, potentially transforming underperforming compounds into next-generation therapies. The recent advancement of Sapu-003 into human trials signals real-world momentum behind this vision, showing how innovation in delivery science can unlock new value across multiple drug candidates. Oncotelic Therapeutics is focused on making its mark in the oncology treatment space, along with other innovative leaders such as…

NetworkNewsWire Editorial Coverage : The AI revolution isn’t running out of processing power; it’s running out of electricity, and the race is on to find the next great source of clean, limitless energy. Data centers are devouring power faster than utilities can supply it, straining aging grids, driving up household energy bills and exposing a simple truth — the digital world needs a new source of real-world power. One breakthrough stands apart: natural hydrogen. According to the International Energy Agency (“IEA”), global data-center power consumption is projected to more than double by 2030, to roughly 945 terawatt-hours (“TWh”), and the subset of AI-optimized centers could quadruple over the same period. Meanwhile, in the United States, power demand from data centers may well double by 2035 as well, potentially consuming around 9% of national electricity demand. In short: Compute demand is outpacing expansion in grid capacity. This is why the big names in tech and capital are now racing to secure energy itself — and one of the most promising sectors in that energy race is natural (geologic) hydrogen . Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX) ( profile ). This first-mover North American public company is focused on commercial natural hydrogen. MAX Power controls approximately 1.3 million permitted acres in Saskatchewan, including the 200-km-long Genesis Trend , which lies adjacent to an existing industrial corridor and a proposed Hydrogen Hub, with multiple ranked targets. With its focus on providing energy for AI demand, MAX Power joins a group of leaders operating in the AI space, including NVIDIA Corp. (NASDAQ: NVDA), Microsoft Corp. (NASDAQ: MSFT), Apple Inc. (NASDAQ: AAPL) and Amazon.com Inc. (NASDAQ: AMZN), whose involvement spans…

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing broad-spectrum antiviral drugs designed to prevent viral escape, will present at the PODD 2025 Conference on Monday, Oct. 27, at 3 p.m. ET in Track 5A at the Westin Copley Hotel, Boston. President and Executive Chairman Anil R. Diwan, PhD, will provide updates on the company’s antiviral drug pipeline and platform technologies available for licensing. NanoViricides’ lead candidate, NV-387, is advancing toward Phase II trials for MPox and respiratory viral infections, with preclinical studies showing strong efficacy against RSV, Influenza A, and Coronaviruses.

Nutriband (NASDAQ: NTRB) today announced that company founder Gareth Sheridan has resumed his role as CEO, effective immediately, following a temporary period during which Co-Founder and Chairman Serguei Melnik served in the position. Sheridan will lead the company through its final 2025 development framework toward an expected 2026 NDA filing for AVERSA Fentanyl, the company’s flagship abuse-deterrent opioid patch. AVERSA Fentanyl is designed to deter misuse and accidental exposure, with potential peak annual U.S. sales estimated between $80 million and $200 million. The AVERSA(TM) technology is protected by patents in 46 countries, including the United States, Europe, and Japan.

Datavault AI (NASDAQ: DVLT), a leader in AI-driven data valuation, monetization, and Web 3.0 asset tokenization, announced a series of strategic expansions aligned with its accelerating growth. The company will relocate its corporate headquarters to downtown Philadelphia, reinforcing its East Coast presence and deepening academic and community ties. Simultaneously, Datavault AI has opened its Center for AI and Quantum Computing Excellence in Sandy Springs, Georgia, a state-of-the-art facility designed for advanced research in AI, quantum computing, and digital twins in collaboration with Georgia Tech and the University of Georgia. The company will maintain its Beaverton, Oregon, site to support WiSA Engineering and Pacific Rim operations, while launching a Quantum Computing & Digital Twin Embassy in London’s Knightsbridge to advance European partnerships. Additionally, Datavault AI has expanded its advisory board to include Dr. John Ratzan, Accenture plc (NYSE: ACN) Financial Services Data and AI North America Lead, and Mr. Mustaq Patel, with further appointments anticipated by the end of October.

Aditxt (NASDAQ: ADTX), a social innovation platform advancing health innovations, announced that its subsidiary Pearsanta Inc. has initiated enrollment in a prospective clinical study evaluating the Mitomic (R) Endometriosis Test (MET(TM)), a novel blood-based diagnostic for early detection of endometriosis. The study will compare MET’s performance to laparoscopic diagnosis, the current gold standard, across up to 1,000 participants referred for surgery. The first site, Dedicated to Women OB/GYN in Dover, Del., has begun enrollment. Pearsanta President Chris Mitton said the milestone supports validation of a non-invasive diagnostic alternative that could enable earlier and more accurate detection of endometriosis.

As Google announces a massive 5 billion euro investment to expand its artificial intelligence (“AI”) infrastructure in Belgium ( ibn.fm/g9GKV ) and unveils new AI capabilities that allow computers to surf the web autonomously ( ibn.fm/e8Vta ), the AI industry faces unprecedented infrastructure challenges. Meanwhile, BluSky AI (OTC: BSAI) is uniquely positioned with its innovative Neocloud platform and modular SkyMod technology. As tech giants pour billions into traditional data center expansion, BluSky AI is focused to democratize access to enterprise-grade AI infrastructure through a fundamentally different approach, delivering compute power in months rather than years.

Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced it has received C$4,316,948 from the exercise of warrants and stock options between July 4 and Oct. 23, 2025, resulting in 334,420,221 common shares outstanding. The proceeds will fund exploration and mine development at the company’s Nevada projects, including the Santa Fe and West Santa Fe sites in the Walker Lane gold belt. CEO Kimberly Ann said the exercises demonstrate strong shareholder confidence and leave Lahontan fully financed for its fall drilling programs while tightening the company’s share structure for future growth.

Branded Legacy (OTC: BLEG), a leader in innovative addiction treatment and harm reduction solutions, announced that its subsidiary, BioLegacy Evaluative Group Inc., has begun engineering and development of a unitary device mold for its proprietary air-driven intranasal drug delivery platform. The milestone advances scalable production of its single-use device for rapid, reliable therapeutic delivery, including its flagship inhaled naloxone program. Building on a September 2025 provisional patent filing and the opening of a GMP-compliant facility in Vancouver, the development strengthens Branded Legacy’s capacity to address the opioid crisis through affordable, high-quality pharmaceutical solutions.

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing therapies for neurodegenerative diseases including Alzheimer’s and Parkinson’s, entered definitive agreements for a registered direct offering of 1,670,732 shares of common stock at $2.05 per share, reflecting the Oct. 24 closing price. The $3.4 million offering, led by H.C. Wainwright & Co. as exclusive placement agent, includes participation from Chairman Michael Hoffman and CEO Dr. Maria Maccecchini. Closing is expected on or about Oct. 28, 2025, with proceeds earmarked for working capital and general corporate purposes.

Beeline Holdings (NASDAQ: BLNE), the digital mortgage lender for next-generation homeowners, announced that its subsidiary, Beeline Loans Inc., has completed the first round of blockchain-recorded BeelineEquity transactions — marking the first large-scale tokenization of U.S. residential home equity. The initial rollout included five completed transactions, with five more scheduled this month and 25 set to close before year-end. BeelineEquity enables homeowners to access liquidity without taking on debt or monthly payments, with each transaction recorded on blockchain for transparency and proof of ownership. CEO Nick Liuzza said the platform “creates a smarter, more transparent financial alternative” as the company targets U.S. markets representing more than $15 trillion in residential equity for 2026 expansion.

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) today announced the appointment of Peter Espig to its Board of Directors, effective immediately. Recognized among Industry Era’s “Top 10 Admired Leaders of 2023,” Espig brings extensive experience guiding resource companies from exploration to production. CEO Jason Barnard said Espig’s expertise will help advance Foremost’s clean energy and critical mineral projects, adding that the recent appointment of Harpreet Bajaj as an officer further strengthens the company’s leadership team. Espig cited Foremost’s strong management, uranium and lithium assets, and NASDAQ listing as key factors positioning the company for growth.

GlobalTech (OTC: GLTK), a U.S.-based tech holding company focused on big data, AI, and digital infrastructure, is revolutionizing enterprise scalability through next-generation infrastructure. The firm made public its partnership with World Mobile Chain, a pioneer blockchain platform designed for decentralized physical infrastructure networks (“DePIN”). The company expects this partnership to strengthen its blockchain capabilities and advance its digital transformation plans ( ibn.fm/GCaK4 ).

As the recent rally in the price of gold and silver seems to be losing steam, the price of platinum group metals, such as platinum has kept rising steadily. This has aroused investor interest in this group of metals, and some are wondering whether the rally will last .

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, will host a stakeholder update call to discuss third-quarter 2025 results on Monday, Nov. 10, 2025, at 5 p.m. ET. The call will be led by CEO Nick Liuzza and CFO Chris Moe, who will review company performance and provide updates on key initiatives.

A months-long legal showdown began on October 20 over who gets to enter Florida’s tightly controlled medical cannabis market, a fight that could reshape one of the state’s fastest-growing industries.

NRx Pharmaceuticals (NASDAQ: NRXP) was featured in a recent article that discussed its approach to bring preservative-free ketamine-based therapies to market, pursuing distinct regulatory and commercial pathways for both KETAFREE(TM) and NRX-100. “The company recently refiled an Abbreviated New Drug Application (‘ANDA’) for KETAFREE(TM), a preservative-free intravenous (‘IV’) ketamine formulation intended for all currently approved ketamine indications,” the article reads. “This filing follows the U.S. Food and Drug Administration’s approval of NRx’s Suitability Petition to eliminate benzethonium chloride (‘BZT’), a chemical preservative still found in many ketamine formulations. BZT, a quaternary ammonium compound, has been associated with cytotoxic and neurotoxic effects. It is no longer considered Generally Recognized as Safe and Effective (‘GRASE’) for parenteral or topical pharmaceutical use. The European Medicines Agency has already discouraged its use in injectable drugs, and the FDA previously removed it from topical antiseptics and hand cleansers over safety concerns… By developing KETAFREE(TM), NRx aims to provide a safer and fully compliant version of ketamine for both hospital and outpatient use, at a time when supply constraints and rising demand have challenged healthcare providers… Alongside the ANDA pathway for KETAFREE(TM), NRx is advancing NRX-100, a separate preservative-free ketamine product, under a New Drug Application (‘NDA’) for the treatment of suicidal depression, including bipolar depression. The formulation has been granted Fast Track Designation by the FDA, positioning it for potential expedited review.”